This PDF is the current document as it appeared on Public Inspection on 03/20/2015 at 11:15 am.
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of First China Pharmaceutical Group, Inc. because it has not filed any periodic reports since the period ended September 30, 2012.
The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EDT on March 20, 2015, through 11:59 p.m. EDT on April 2, 2015.Start Signature
By the Commission.
Jill M. Peterson,
[FR Doc. 2015-06795 Filed 3-20-15; 11:15 am]
BILLING CODE 8011-01-P